CWM
MXCT icon

CIBC World Markets’s MaxCyte MXCT Stock Holding History

CIBC World Markets’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$27.2K Sell
12,460
-11,021
-47% -$26.7K ﹤0.01% 1513
2025
Q1 		$64.1K Buy
+23,481
New +$92.6K ﹤0.01% 1676

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC World Markets's MXCT Position: Q2 2025 in Review

CIBC World Markets reduced its MaxCyte (MXCT) stake by 47% in Q2 2025, selling an estimated $26.7K and leaving 12,460 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1513.

CIBC World Markets first reported a position in MXCT in Q1 2025 and has held it in 2 quarters since. The position peaked at $64.1K in Q1 2025. 120 funds tracked by Wall St. Rank hold MXCT as of Q2 2025.

  • CIBC World Markets held 12,460 shares of MaxCyte worth $27.2K as of Q2 2025.
  • CIBC World Markets sold 11,021 MaxCyte shares in Q2 2025, an estimated $26.7K.
  • MaxCyte made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1513 holding.
  • CIBC World Markets first reported a position in MaxCyte in Q1 2025 and has held it in 2 quarters since.
  • CIBC World Markets's MaxCyte position peaked at $64.1K in Q1 2025.
  • 120 funds tracked by Wall St. Rank held MaxCyte as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.